This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
What You Should Know: – Paige, a provider of AI-powered pathology solutions, to...
What You Should Know: – Commure, a healthcare technology company, today announc...
What You Should Know: – myTomorrows, a global health technology company co...
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing...
The following is a guest article by Muhammad Shujja, Digital Marketing Lead at A...
Plus, news about X4 Pharmaceuticals, Viracta Therapeutics, Crown Laboratories, Q...
It took one month for Johnson & Johnson to secure its $14 billion acquisition of...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...
AstraZeneca has terminated all development of vemircopan, the oral factor D inhi...
We’re in dealmaking season for publicly traded digital health companies. In ...
Almost 16 years after Rituxan's disappointing data in lupus, Roche's Genentech f...
A trade group representing 1,600 hospitals says 340B rebate models proposed by m...
The shift to a VBC model represents more than an evolution in healthcare deliver...
Investors showed appetite for Metsera’s IPO, as shares of the clinical-stage met...
Currently available therapies for Hunter syndrome don’t cross the blood-brain ba...
Regulators will have their work cut out for them under a new administration that...